These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 855972

  • 1. [Inhibitors of fibrinolysis in the human placenta. Histochemical study].
    Fornasari PM, Sora A, Bolis PF, Guaschino S.
    Ann Ostet Ginecol Med Perinat; 1977; 98(2):104-7. PubMed ID: 855972
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M.
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Thromboplastic and fibrinolytic activity of the tissues of pregnant uterus and the elements of fertilized ovum].
    Vdovina GF, Skipetrov VP, Azbukina LN.
    Vopr Okhr Materin Det; 1975 Jun; 20(6):75-9. PubMed ID: 1136329
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of tissue activator by urokinase inhibitor.
    Kawano T, Uemura Y.
    Thromb Diath Haemorrh; 1971 Jun; 25(1):129-33. PubMed ID: 5577966
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Histochemical method to detect antiproteolytic activity in tissues.
    Fornasari PM, Gratton L, Gamba G.
    Boll Soc Ital Biol Sper; 1976 Jun 15; 52(11):758-60. PubMed ID: 1016623
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Method of determination of fibrinolysis inhibitors in biological material].
    Richter M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967 Jun 15; 87(1):123-7. PubMed ID: 4173873
    [No Abstract] [Full Text] [Related]

  • 15. [Occurrence and treatment of a hyperfibrinolytic event after spontaneous delivery].
    Oberheuser F, Goris J, Hörder MH.
    Zentralbl Gynakol; 1967 Oct 21; 89(42):1544-8. PubMed ID: 5301539
    [No Abstract] [Full Text] [Related]

  • 16. Changes in human amniotic fluid fibrinolytic inhibitor levels during pregnancy.
    Aznar J, Hernandez A, Parrilla JJ, Estelles A, Gilabert J.
    Thromb Haemost; 1976 Apr 30; 35(2):382-5. PubMed ID: 989638
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The fibrinolytic activity of the endometrium and myometrium, decidua and placenta and cervical and corpus carcinomas. Physiology, pathology and clinico-therapeutic consequences].
    Schmidt-Matthiesen H.
    Bibl Gynaecol; 1967 Apr 30; 44():1-117. PubMed ID: 5302142
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Determination of the activity of inhibitors of fibrinolysis in pregnancy. I. Preparation of plasminogen].
    Panazzolo A, Giambanco V, Scarpa F.
    Boll Soc Ital Biol Sper; 1967 Sep 30; 43(18):1172-3. PubMed ID: 6073074
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.